|
|
|
'Cancer Research' Has Published a Paper on the Activity of MM-121, an ErbB3 Inhibitor, in Ligand-dependent Tumors
Posted By: Anonymous | Posted On: Mar 15,2010 18:30 pm | View: 16
Dana-Farber Cancer Institute, Massachusetts General Hospital Cancer Center, Dana-Farber/Harvard Cancer Center, Cell Signaling Technology, Harvard Medical School and Merrimack Pharmaceuticals collaborated on the MM-121 research. Researchers looked at MM-121 in combination with Erbitux to study efficacy in preclinical cancer models resistant to other targeted therapies.
Read More: http://www.prweb.com/releases/2010/03/prweb3733734.htm
|
|
| Latest Videos : |
|
Learn Hacking with IDLE BRAIN | Cyb3r Command0s
https://www.youtube.com/channel/UC7hbQtQ_fCFTRBIezoM0Yiw?sub_confirmation=1 |
|
Breast Cancer Prevention - Dr. Jennifer Walden
Dr. Walden is a premier Manhattan Plastic Surgeon, and is often asked to comment, as a medical expert, on CBS, ABC, Fox News, and other media outlets. Dr. Walden has covered issues including current cosmetic surgery, breast augmentation, prevention of breast cancer, and many other topics. Watch as Dr. Walden gives some good information on Breast Ca |
|
Liver Cancer
Liver Cancer |
|
Diet and Cancer Prevention
Learn what to eat to prevent cancer.
Dietary habits are the habitual decisions an individual or culture makes when choosing what foods to eat. Although humans are herbivores, each culture holds some food preferences and some food taboos. Individual dietary choices may be more or less healthy. Proper nutrition requires the proper ingestion and eq |
|
Prostate Cancer
Animation explaining what prostate cancer is, provided by Dr. Rajaratnam. DrRajMD.com |
|
|
|
|
|
